Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, rampril, and their combination in high-risk patients : The ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE intolerant subjects with cardiovascular disease (ONTARGET/TRANSCEND) trials
José Antônio Marin Neto
American Heart Journal St. Louis v. 148, n. 1, p. 52-61, 2004St. Louis 2004
Localização: FMRP - Fac. Medicina de Ribeirão Preto (pcd 1400480 )(Acessar)